Stockreport

Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier® Binds to Extracellular Vesicles in Long COVID patient samples and Decreas...

Aethlon Medical, Inc.  (AEMD) 
NASDAQ:AMEX Investor Relations: ir.aethlonmedical.com
PDF Results Support the Further Investigation of the Hemopurifier in Long COVIDSAN DIEGO, Dec. 2, 2025 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therap [Read more]